Product description

Fields of Application: Parkinson's disease. Carbidopa, an aromatic L-amino acid decarboxylase inhibitor, which does not cross the blood-brain barrier, is routinely administered in combination with levodopa to patients with Parkinson’s disease to reduce the peripheral decarboxylation of levodopa to dopamine.
Read more

Specifications

Model CEP, DMF
Categories APIs (Active Pharmaceutical Ingredients)
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Switzerland
Measured In piece
Selling Points Brand Name; Experienced Technicians; International Approvals/Standards; Place of Origin; Prompt Delivery; Quality Service; Reputation

More products from Bachem AG

View all our products (24)

Products from other suppliers